Other OTC Pharmaceuticals (Pharmacies) - Uzbekistan

  • Uzbekistan
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$22.37m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.34%, resulting in a market volume of US$26.36m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.63 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Uzbekistan is experiencing significant growth and development in recent years.

Customer preferences:
Customers in Uzbekistan are increasingly turning to over-the-counter (OTC) pharmaceutical products for their healthcare needs. This can be attributed to several factors. Firstly, customers are becoming more health-conscious and are taking proactive measures to maintain their well-being. OTC pharmaceuticals provide a convenient and accessible solution for common ailments and minor health issues. Secondly, the affordability of OTC products compared to prescription medications is appealing to customers, especially those who may not have health insurance coverage. Additionally, the availability of a wide range of OTC products in pharmacies allows customers to choose the most suitable option for their needs.

Trends in the market:
One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in Uzbekistan is the increasing demand for vitamins and dietary supplements. As customers become more health-conscious, they are seeking ways to enhance their overall wellness. Vitamins and dietary supplements are seen as a way to bridge any nutritional gaps and support overall health. This trend is driven by a growing awareness of the importance of a balanced diet and the role that supplements can play in maintaining optimal health. Another trend in the market is the rising demand for OTC pain relief products. These products, such as analgesics and topical creams, provide a convenient and accessible solution for customers seeking relief from minor aches and pains. The busy and fast-paced lifestyle of customers in Uzbekistan may contribute to the prevalence of such products, as they offer quick and effective relief without the need for a doctor's prescription.

Local special circumstances:
The Other OTC Pharmaceuticals (Pharmacies) market in Uzbekistan is influenced by several local special circumstances. Firstly, the country has a well-established network of pharmacies that provide easy access to OTC products. Pharmacies are typically located in urban areas and are easily accessible to customers. This accessibility plays a crucial role in driving the growth of the OTC market in Uzbekistan. Additionally, the government of Uzbekistan has taken steps to promote the use of OTC pharmaceuticals. This includes initiatives to educate the public about the benefits of OTC products and their appropriate use. Such efforts contribute to the increasing acceptance and adoption of OTC pharmaceuticals among customers.

Underlying macroeconomic factors:
The growth and development of the Other OTC Pharmaceuticals (Pharmacies) market in Uzbekistan can be attributed to several underlying macroeconomic factors. Firstly, the country has experienced steady economic growth in recent years, which has resulted in an increase in disposable income levels. As customers have more purchasing power, they are more likely to spend on healthcare products, including OTC pharmaceuticals. Furthermore, the government's focus on healthcare and well-being has also contributed to the growth of the OTC market. Investments in healthcare infrastructure and initiatives to improve access to healthcare services have created a favorable environment for the OTC pharmaceutical industry to thrive. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Uzbekistan is developing due to customer preferences for accessible and affordable healthcare solutions, including vitamins, dietary supplements, and pain relief products. Local special circumstances, such as the availability of pharmacies and government initiatives, further support this growth. Underlying macroeconomic factors, including economic growth and government investments in healthcare, also contribute to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)